A Rare Brain Disorder linked to Measles is now under the spotlight as a Hyderabad-based institute launches a new Research Study.
Tatva Chintan's Q1 Surprise pushed the company's shares up by 18% on strong first-quarter earnings. Tatva Chintan gained 18.13% to Rs 1,687 after reporting sharp growth in profit and revenue.
People with type 2 diabetes face a higher severe dengue risk, according to a new study. Researchers found the condition can increase the chances of dangerous dengue complications.
Novo Nordisk’s Wegovy gains CDSCO approval for MASH in India, marking a key GLP-1 expansion into liver disease, strengthening its role in metabolic disorder treatment.
A wave of strategic deals, policy momentum, and technological breakthroughs defined the week for India’s drug manufacturers
India’s pharmaceutical sector is entering a transformative phase with AI and biologics powering the pharma innovation that will reshaping the industry’s future
Most office jobs today involve sitting for eight hours or more. Screens have replaced walking, and meetings have replaced movement.
India’s pharmaceutical ambitions are entering a decisive phase with the government announcing Rs 1,500 crore assistance fund
The global obesity treatment landscape is entering a transformative phase, As the new oral therapy begins to redefine patient's access to and adherence to weight loss medications
Biogen’s continued focus on developing an effective alzhiemers drug reflects progress and uncertainty in the global fight against the disease
, CDSCO.jpg)